COPD and gastrointestinal diseases have a significant bidirectional association, with depressive symptoms serving as a key mediator.

Market OverviewThe global gastrointestinal stent market is projected to grow at a CAGR of around 6% over the forecast period. Key factors driving this growth include the rising prevalence of ...

Amiko Uchida, MD, a gastroenterologist at University of Utah Health in Salt Lake City, was named a 2026 Young ...

To access the live webcast and archived recordings of the event, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. A ...

A sweeping scientific review reveals how regular exercise reshapes the gut microbiome, reduces inflammation, and lowers the risk for gastrointestinal disease.

A 2026 Young Physician-Scientist Award honors Uchida's work in immune-mediated gastrointestinal disease and her translation of discoveries into better patient care.

While other weight-loss drugs have caused similar problems, one expert said GLP-1 medications have a far greater impact ...

Background Post-infection disorders of gut-brain interaction (PI-DGBI) are a subset of chronic gastrointestinal disorders triggered by acute infectious gastroenteritis. These conditions impose a ...

Asante Gastroenterology has officially opened its doors in Medford, marking a significant step for gastrointestinal care in ...

Brazilian magnetic capsules may expand access to gastrointestinal motility testing without radiation, but clinical validation ...

Global Surgery Program, in partnership with George Regional Hospital in South Africa, reports that a traveling mobile ...

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...